Lonicerin alleviates LPS-evoked inflammation and apoptosis in HK2 cells
Main Article Content
Keywords
inflammation, lonicerin, LPS, sepsis-evoked acute kidney injury
Abstract
Background: Sepsis-induced acute kidney injury (AKI) is one of the most common complications of sepsis, characterized by extensive renal inflammation and progressive tissue damage, and poses a serious threat to human health. Lonicerin, a flavonoid glycoside derived from Lonicera japonica Thunb., is reported to exert beneficial effects in various inflammatory diseases. However, its potential regulatory role in sepsis-induced AKI has not been elucidated completely.
Objective: To investigate the regulatory impacts of lonicerin in sepsis-induced AKI.
Material and Methods: The cell viability was evaluated through CCK-8 assay. The LDH levels were examined through the LDH assay kit. The mRNA expression levels were analyzed through RT-qPCR. The levels of TNF-α, IL-6, and IL-1β were determined through ELISA. The ROS levels were detected through the DCF staining. Apoptosis rates were determined by flow cytometry. Protein expression levels were analyzed by western blot.
Results: In this study, we demonstrated that lonicerin enhanced the viability of HK2 cells following lipopolysaccharide (LPS) stimulation. LPS significantly increased the inflammatory response, whereas this effect was attenuated after treatment with lonicerin. Furthermore, lonicerin effectively suppressed LPS-induced oxidative stress. In addition, although LPS stimulation promoted apoptosis in HK2 cells, this pro-apoptotic effect was largely counteracted by administration of lonicerin. Mechanistically, we found that activation of the nuclear factor kappa-B signaling pathway by LPS was inhibited in the presence of lonicerin.
Conclusion: our findings provide that lonicerin can mitigate LPS-induced inflammation, oxidative stress, and apoptosis in HK2 cells. These results suggest that lonicerin may represent a promising therapeutic candidate for treating sepsis-induced AKI.
References
2 Bülbül E, Toker I, Cephe A, Gençaslan MA, Yüce ZT, Muhtaroğlu S, et al. Diagnostic value of asprosin for sepsis: A case-control study in the emergency department. Signa Vitae. 2024;20(12):86–92. 10.22514/sv.2024.159
3 Manrique-Caballero CL, Del Rio-Pertuz G, and Gomez H. Sepsis-associated acute kidney injury. Crit Care Clin. 2021;37(2):279–301. 10.1016/j.ccc.2020.11.010
4 Sazonov V, Abylkassov R, Tobylbayeva Z, Saparov A, Mironova O, Poddighe D. Case series: Efficacy and safety of hemoadsorption with HA-330 adsorber in septic pediatric patients with cancer. Front Pediatr. 2021;9:672260. 10.3389/fped.2021.672260
5 Pastores SM. Drotrecogin alfa (activated): A novel therapeutic strategy for severe sepsis. Postgrad Med J. 2003;79(927):5–10. 10.1136/pmj.79.927.5
6 Mahmoud AM,Sayed AM, Ahmeda AF, Abd-Alhameed EK, Salem SH, Alruhaimi RS, et al. Flavonoids-mediated TLR4 inhibition as a promising therapy for renal diseases. Comb Chem High Throughput Screen. 2023;26(12):2124–48. 10.2174/1386207326666230116124532
7 Xia S, Lin H, Liu H, Lu Z, Wang H, Fan S, et al. Honokiol attenuates sepsis-associated acute kidney injury via the inhibition of oxidative stress and inflammation. Inflammation. 2019;42(3):826–34. 10.1007/s10753-018-0937-x
8 Zheng S, Xue T, Wang B, Guo H, Liu Q. Chinese medicine in the treatment of ulcerative colitis: The mechanisms of signaling pathway regulations. Am J Chin Med. 2022;50(7):1781–98. 10.1142/S0192415X22500756
9 Yao Z, Liang Y, Pan C, Zeng K, Qu Z. Lonicerin alleviates intestinal myenteric neuron injury induced by hypoxia/reoxygenation treated macrophages by downregulating EZH2. J Biochem Mol Toxicol. 2024;38(9):e23810. 10.1002/jbt.23810
10 Lv Q, Xing Y, Liu J, Dong D, Liu Y, Qiao H, et al. Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation. Acta Pharm Sin B. 2021;11(9):2880–99. 10.1016/j.apsb.2021.03.011
11 Deng Z, Zhang X, Wen J, Yang X, Xue L, Ou C, et al. Lonicerin attenuates house dust mite-induced eosinophilic asthma through targeting Src/EGFR signaling. Front Pharmacol. 2022;13:1051344. 10.3389/fphar.2022.1051344
12 Yang X, Qian H, Meng J, Jiang H, Yuan T, Yang S, et al. Lonicerin alleviates the progression of experimental rheumatoid arthritis by downregulating M1 macrophages through the NF-κB signaling pathway. Phytother Res. 2023;37(9):3939–50. 10.1002/ptr.7853
13 Li D, Li C, Jiang S, Wang T, Zhang C, Zhu Z, et al. Lonicerin protects pancreatic acinar cells from caerulein-induced apoptosis, inflammation, and ferroptosis by activating the SIRT1/GPX4 signaling pathway. Toxicol Appl Pharmacol. 2024;492:117136. 10.1016/j.taap.2024.117136
14 Dai R, Xiang Y, Fang R, Zheng H, Zhao Q, Wang Y, et al. Lonicerin alleviates ovalbumin-induced asthma of mice via inhibiting enhancer of zeste homolog 2/nuclear factor-kappa B signaling pathway. Exp Anim. 2024;73(2):154–61. 10.1538/expanim.23-0068
15 Poma P. NF-κB and disease. Int J Mol Sci. 2020;21(23):9181. 10.3390/ijms21239181
16 Balkrishna A, Sinha S, Kumar A, Arya V, Gautam AK, Valis M, et al. Sepsis-mediated renal dysfunction: Pathophysiology, biomarkers and role of phytoconstituents in its management. Biomed Pharmacother. 2023;165:115183. 10.1016/j.biopha.2023.115183
17 Wang Y, Xi W, Zhang X, Bi X, Liu B, Zheng X, et al. CTSB promotes sepsis-induced acute kidney injury through activating mitochondrial apoptosis pathway. Front Immunol. 2022;13:1053754. 10.3389/fimmu.2022.1053754
18 Deng F, Zhang H, Zhou W, Ma S, Kang Y, Yang W, et al. TRPA1 promotes cisplatin-induced acute kidney injury via regulating the endoplasmic reticulum stress-mitochondrial damage. J Transl Med. 2023;21(1):695. 10.1186/s12967-023-04351-9
19 Ow CPC, Trask-Marino A, Betrie AH, Evans RG, May CN, Lankadeva YR, et al. Targeting oxidative stress in septic acute kidney injury: From theory to practice. J Clin Med. 2021;10(17):3798. 10.3390/jcm10173798
20 Zhang W, Chen H, Xu Z, Zhang X, Tan X, He N, et al. Liensinine pretreatment reduces inflammation, oxidative stress, apoptosis, and autophagy to alleviate sepsis acute kidney injury. Int Immunopharmacol. 2023;122:110563. 10.1016/j.intimp.2023.110563
21 Liu D, Li L, Li Z. Anemonin inhibits sepsis-induced acute kidney injury via mitigating inflammation and oxidative stress. Biotechnol Appl Biochem. 2023;70(6):1983–2001. 10.1002/bab.2504
22 Gong M, Li L, Li Z. PHLDA1 knockdown inhibits inflammation and oxidative stress by regulating JNK/ERK pathway, and plays a protective role in sepsis-induced acute kidney injury. Allergol Immunopathol (Madr). 2022;50(6):1–9. 10.15586/aei.v50i6.671
23 Wang Y, Lv W, Ma X, Diao R, Luo X, Shen Q, et al. NDUFS3 alleviates oxidative stress and ferroptosis in sepsis induced acute kidney injury through AMPK pathway. Int Immunopharmacol. 2024;143(Pt 2):113393. 10.1016/j.intimp.2024.113393
24 Kim K, Hong H, Kim GM, Leem J, Kwon HH. Eupatilin ameliorates lipopolysaccharide-induced acute kidney injury by inhibiting inflammation, oxidative stress, and apoptosis in mice. Curr Issues Mol Biol. 2023;45(9):7027–42. 10.3390/cimb45090444
25 Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-κB pathway for the therapy of diseases: Mechanism and clinical study. Signal Transduct Target Ther. 2020;5(1):209. 10.1038/s41392-020-00312-6
26 Liang J, Li B, Xia Y. MicroR-380-3p reduces sepsis-induced acute kidney injury via regulating RAB1P to restrain NF-κB pathway. Tohoku J Exp Med. 2024;263(1):69–79. 10.1620/tjem.2023.J106
27 Li M, Tong W, Dai C, Lu G, Jin D, Deng F. Downregulation of the immunoproteasome subunit PSMB8 attenuates sepsis-associated acute kidney injury through the NF-κB pathway. Immunobiology. 2024;230(1):152862. 10.1016/j.imbio.2024.152862
28 Tang Y, Wang C, Wang Y, Zhang J, Wang F, Li L, et al. Isoliquiritigenin attenuates LPS-induced AKI by suppression of inflammation involving NF-κB pathway. Am J Transl Res. 2018;10(12):4141–51.
29 Liu T, Zhang Y, Liu X, Zuo Z. Fortunellin attenuates sepsis-induced acute kidney injury by inhibiting inflammation and ferroptosis via the TLR4/NF-κB pathway. Histol Histopathol. 2024;18841:1083–93. 10.14670/HH-18-841
